Beam Stock Analysis Beam Therapeutics Inc. Biotech Stock Gains 1.82 Percent At 24.66 Level 20260403 1 GNK Q1 2026 Earnings Massive EPS Surprise of 34293 Driven by Strong Operational Leverage ColgatePalmolive Q1 2026 Earnings Slight EPS Miss Amid Positive Stock Movement CNB Financial Corporation Q1 2026 Earnings EPS Beats Estimates by 74 as Stock Declines CEPT Q1 2026 Earnings Strong EPS Beat Drives Share Price Uplift Cerus Corporation CERS Q1 2026 Earnings EPS Surprises to the Upside as Loss Narrows Veris Residential Inc VRE Q4 2025 Earnings NarrowerThanExpected Loss Highlights Operational Discipline